Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma - Wikidata - wikimedia - TriplyDB

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

http://www.wikidata.org/entity/Q35815596

about

Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation Histone variant H3F3A promotes lung cancer cell migration through intronic regulation HistoneDB 2.0: a histone database with variants--an integrated resource to explore histones and their variants Multivalent binding of PWWP2A to H2A.Z regulates mitosis and neural crest differentiation.Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.BALB/c-congenic ANP32B-deficient mice reveal a modifying locus that determines viability.Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer.The prognostic potential of alternative transcript isoforms across human tumors.Genome-wide identification of histone H2A and histone variant H2A.Z-interacting proteins by bPPI-seq.Histone Hypervariants H2A.Z.1 and H2A.Z.2 Play Independent and Context-Specific Roles in Neuronal Activity-Induced Transcription of Arc/Arg3.1 and Other Immediate Early Genes.H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs Patching Broken DNA: Nucleosome Dynamics and the Repair of DNA Breaks Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.Histone variants expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis.Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.Histone variants and melanoma: facts and hypotheses.Genetic complementation analysis showed distinct contributions of the N-terminal tail of H2A.Z to epigenetic regulations.ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: progresses and future directions.H3.Y discriminates between HIRA and DAXX chaperone complexes and reveals unexpected insights into human DAXX-H3.3-H4 binding and deposition requirements.Barcelona conference on epigenetics and cancer 2015: Coding and non-coding functions of the genome.Histone variant H2A.Z.2: A novel driver of melanoma progression.Dynamic changes in chromatin states during specification and differentiation of adult intestinal stem cells RNF2 E3 or Not to E3: Dual Roles of RNF2 Overexpression in Melanoma.Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.SUMO modification system facilitates the exchange of histone variant H2A.Z-2 at DNA damage sites.Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.Brain-specific deletion of histone variant H2A.z results in cortical neurogenesis defects and neurodevelopmental disorder.Specific Acetylation Patterns of H2A.Z Form Transient Interactions with the BPTF Bromodomain.The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries.PWWP2A: A novel mitosis link?Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.Characterization of mussel H2A.Z.2: a new H2A.Z variant preferentially expressed in germinal tissues from Mytilus.The tale of a tail: histone H4 acetylation and the repair of DNA breaks.Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma.Altered primary chromatin structures and their implications in cancer development.Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer.Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.

P2860

Q26783032-DE0CB51E-B35A-4081-8E11-22F0233A016B Q28116488-1DB30F4F-A016-43A4-ABF9-B0DD4998BF6E Q33631126-2E114991-B8EE-446B-BE1E-CC4FB41B9C48 Q33815687-3CBEF387-538B-4175-8DC8-2D965E0D28C0 Q34518747-D893296A-5632-4F3F-A4F1-6E0EF8F309E2 Q36413697-309EBC43-7595-4123-A00A-9A99C32D850B Q36553263-DBD2AE09-F5D7-455F-BAF0-0CF2A5E0482B Q36666339-F546E0CE-478E-41B5-BB0E-C87B302AB4ED Q36998267-25F6AFD4-7B76-4052-9D4F-541F87918FA9 Q37185523-29B6C120-6716-4870-B3B2-E862FB36A04D Q38598206-B6F068A3-8714-4AD2-8D51-E4908785E0FD Q38601242-A87E2E70-426C-4990-9446-3EC2908DBD07 Q38608843-ECBEAB36-86FA-4E34-8C90-C99F3AC24AC3 Q38655184-D8EA0C6B-8254-4D7F-9539-34552936E7AB Q38660042-0838E04F-A62D-4058-B739-6D0A4A03A73F Q38668583-6CEEF3E0-31D7-4D06-B23E-277DD00070FC Q38707876-46E76EB8-2E03-48A2-A7FB-BB7B9240E577 Q38748010-1FC4F94F-74AB-44A7-AEB2-F38D2745786B Q38797473-14B72D4A-AADC-4392-8A1E-7360A374790A Q38851252-83F6591D-E2EC-4B54-88B0-6FC060AB99B9 Q38882222-73066751-1567-4300-8532-24D1C8DADB95 Q40658995-12A6E370-AF2E-4EAF-9EB6-CF1138D6C25A Q41830673-4673156A-126F-493D-AC2F-E41F448C539E Q42237145-C8A564B9-62AD-49FB-9EA1-85F021A4388D Q42537302-64C2132D-DB9C-4397-ABD8-89D9B1DD962D Q46230467-EF39CDDB-04FB-4D94-81B1-B4DEFF1414F8 Q47388205-456F0549-D858-44AE-9CE2-91BEC0BE9555 Q47391313-96C6F9F9-52BF-48E1-A6F0-2163C87E9A0B Q47886733-6B6DB72D-A08C-4C20-8AB2-EC4F3051F6B4 Q47996220-220BB13A-4545-4D1D-9966-34B5D1262FCF Q49484906-A8A2C501-4132-4593-B09B-C30AD0BE23A3 Q49964013-C3682EE0-6154-4C5B-9DDC-822C2EBEF2B5 Q50044075-06AC5771-AE7F-4FD0-AC9D-D5DB7334F8EE Q51518774-062DDF22-AA4C-403A-A7A0-62007748B97A Q52532574-399F87C3-AF32-4574-865F-B5F32F34C58B Q52591043-170F88A7-C52C-4B3F-BF81-4B2CC0B08C43 Q52658575-5119E413-F15B-4F46-AF7E-DCEAEB03AF8A Q52878923-37A85270-7A3C-41C1-806C-07C4FDCCEAD5 Q53827263-EE57F9D7-FACF-4A01-BCAE-499179A1913C Q55092089-C30070FF-996E-4398-8CA0-E6D9ADBB7ED0

P2860

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

http://www.wikidata.org/entity/Q35815596

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@ast

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@en

type

label

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@ast

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@en

prefLabel

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@ast

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@en

P1433

Q35815596-D4F4222A-2B97-4041-9FAE-AEAC4E6B00C2

P1476

Q35815596-DC880499-E046-4F51-A9ED-9371437AA42D

P2093

Q35815596-05F820FE-971F-41A3-B628-E0E85C81D5DF

Q35815596-18FA9C9B-1D36-42AB-A444-56C07BE21C39

Q35815596-2DE14609-2D60-41A8-85DD-21F58FAFB7B7

Q35815596-2F1CD15F-A7B4-48F1-9F03-F80062549C8E

Q35815596-2F69B1C2-B005-42BE-81FA-E6712017526E

Q35815596-5B3DB2B8-4572-4F2F-8FF8-6BB49CAB2D41

Q35815596-783C31E1-CA82-4F60-B37A-A13BD1CB7D7C

Q35815596-831A1AF8-0CF8-4218-809B-FCD105C6F9C4

Q35815596-8A1FA371-0AE0-4751-ADCB-7B106AD96F42

Q35815596-ADB25BC4-ACD1-4236-AC8C-F06ABB3E22E3

P2860

Q35815596-00D2A4E1-8CF1-42CA-9340-6ACB8E85F5A7

Q35815596-02CEAB47-1E61-4479-8FAE-451CA694F85E

Q35815596-13DF79B0-0737-40B9-ADAD-3975029F6517

Q35815596-15180866-BCD9-4476-97C1-7E4E200D2862

Q35815596-1855139F-7562-4346-BD61-8293EA49A7DB

Q35815596-1E6DDF79-F253-4134-A341-C82B133E413E

Q35815596-320FB990-FC64-4E34-AFAB-5AC7FDE3C6FA

Q35815596-389E7A7C-8B4E-44BD-93EF-32E563BA68CF

Q35815596-3CADB628-9612-45FB-A669-CB0A78F89B37

Q35815596-43C109C3-E9CF-428D-A1F3-4920678550C3

P304

Q35815596-7D5A6082-7619-4594-9979-98087F9DDBF9

P31

Q35815596-FEF75DE0-1CAA-4998-87E1-ACE137B7379E

P356

Q35815596-60998D00-98A9-444A-9E40-DC59072DFCBC

P433

Q35815596-CF252427-6042-4EEF-AE3A-ED5B65A43695

P478

Q35815596-C2914FB9-0C68-405D-AF64-AC6039BAC9D3

P50

Q35815596-8867C0A2-75C5-4913-BDEF-2447E01B23C1

Q35815596-BA6A120F-1195-4767-A106-FE9E9A3B912B

Q35815596-C7260E49-C2BF-4D7B-AADD-2132D4DFC639

Q35815596-DB8D60EC-B4B1-4E7A-BF76-9516C13794FB

Q35815596-ED98A4EE-8063-43B2-905E-65BB3A946588

Q35815596-EDA8B8EB-F984-4BEB-8B65-DF645896DBB0

P577

Q35815596-5CDC8ABA-3F2A-4C7E-A9E0-543BA186262A

P5875

Q35815596-D622FDDA-A7CE-4672-9568-206C4314F85D

P698

Q35815596-476B6E24-86F0-4ABE-819B-AB0E2DA5774B

P932

Q35815596-E85CAC93-162E-427D-91E9-80F1C7660341

P356

J.MOLCEL.2015.05.009

P1433

P1476

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

@en

P2093

Amit Verma

http://www.w3.org/2001/XMLSchema#string

Barbara Fontanals-Cirera

http://www.w3.org/2001/XMLSchema#string

Chi-Yeh Chung

http://www.w3.org/2001/XMLSchema#string

Chiara Vardabasso

http://www.w3.org/2001/XMLSchema#string

Dan Hasson

http://www.w3.org/2001/XMLSchema#string

Emily Bernstein

http://www.w3.org/2001/XMLSchema#string

Eva C Keilhauer

http://www.w3.org/2001/XMLSchema#string

Joanna Dong

http://www.w3.org/2001/XMLSchema#string

Jonathan L Yao

http://www.w3.org/2001/XMLSchema#string

Matthias Mann

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription

ANP32E is a histone chaperone that removes H2A.Z from chromatin

RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Structural polymorphism in the L1 loop regions of human H2A.Z.1 and H2A.Z.2

High-resolution profiling of histone methylations in the human genome

Histone variant H2A.Z is required for early mammalian development

E2F1 in melanoma progression and metastasis

P304

75-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLCEL.2015.05.009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

David Valle-Garcia

Alexandre Gaspar-Maia

Miguel F Segura

P577

2015-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277720236

http://www.w3.org/2001/XMLSchema#string

P698

26051178

http://www.w3.org/2001/XMLSchema#string

P932

4490946

http://www.w3.org/2001/XMLSchema#string